Business Context and Reporting Period
This Form 8-K Current Report was filed by vTv Therapeutics Inc. on August 31, 2020. The filing reports a corporate governance event rather than financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the appointment of a new director.
Material Changes
On August 31, 2020, the Board of Directors appointed Edward P. Taibi as a member of the Board, effective immediately. Mr. Taibi will serve a term through the date of the next annual meeting of stockholders. He is an Executive Vice President of MacAndrews & Forbes Incorporated, a related party to the Company. As of the filing date, Mr. Taibi has not been appointed to any Board Committee.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It notes that Mr. Taibi will not receive compensation for his Board service due to his existing employment at MacAndrews & Forbes Incorporated.
Investor Verification Checklist
- Verify the relationship between vTv Therapeutics Inc. and MacAndrews & Forbes Incorporated.
- Confirm the background and qualifications of the newly appointed director, Edward P. Taibi.
- Review the Company's most recent 10-Q or 10-K for actual financial performance data, as this 8-K does not contain financial statements.